Literature DB >> 11456438

Advances in the treatment of epilepsy.

S R Benbadis1, W O Tatum.   

Abstract

Significant advances have been made in the diagnosis and treatment of epilepsy over the past decade. With the advent of electroencephalographic video monitoring, physicians are now able to reliably differentiate epilepsy from other conditions that can mimic it, such as pseudoseizures. In addition, neuroimaging has changed the way treatment for difficult epilepsy is approached. As a result, the classification systems that have been in use since the early 1980s are currently being revised. A broader range of treatment options for epilepsy is now available. Many new antiepileptic drugs have become available in recent years, including felbamate, gabapentin, lamotrigine, topiramate, tiagabine, levetiracetam, oxcarbazepine and zonisamide. These medications offer options for patients with epilepsy whose seizures cannot be controlled using the classic agents. Several classic antiepileptic drugs have been modified and reformulated. The ketogenic diet has resurfaced as a treatment option in certain types of epilepsy. The vagus nerve stimulator, approved in 1997, represents a completely new treatment modality for patients with seizures not controlled by medications. Epilepsy surgery is now a well-documented and effective treatment for some patients with intractable epilepsy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11456438

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  3 in total

1.  Uses of Newer Anticonvulsants: An Update.

Authors:  Timothy R. Berigan
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2002-10

2.  Ketogenic diet decreases circulating concentrations of neuroactive steroids of female rats.

Authors:  Madeline E Rhodes; Jayanth Talluri; Jacob P Harney; Cheryl A Frye
Journal:  Epilepsy Behav       Date:  2005-09       Impact factor: 2.937

Review 3.  Regenerative medicine for epilepsy: from basic research to clinical application.

Authors:  Takao Yasuhara; Takashi Agari; Masahiro Kameda; Akihiko Kondo; Satoshi Kuramoto; Meng Jing; Tatsuya Sasaki; Atsuhiko Toyoshima; Susumu Sasada; Kenichiro Sato; Aiko Shinko; Takaaki Wakamori; Yu Okuma; Yasuyuki Miyoshi; Naoki Tajiri; Cesario V Borlongan; Isao Date
Journal:  Int J Mol Sci       Date:  2013-11-28       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.